What's breaking now, across thousands of outlets.
(RTTNews) - Eisai Co. (4523.T, EII.SG) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection - LEQEMBI IQLIK - is now available in the U.S. for initiation therapy for early Alzheimer's disease in adults with mild cognitive impairment or mild dementia
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Peter Mac researchers have identified potential new drug targets for pancreatic cancer by uncovering proteins cancer cells rely on to grow and survive.
Blessing Ibunge in Port Harcourt Founder of Save-A-Life Mission Hospital, Port Harcourt, Dr Richard Okoye, has said Nigeria can reverse its medical tourism trend and improve its poor life expectancy…
What if the device keeping your heart beating was entirely man-made? Inside a high-precision manufacturing facility in Singapore, trained mostly women operators sit behind microscopes, carefully…
The amendments to the Medical Devices Rules, 2017, seek to simplify regulatory requirements, standardise testing fees and facilitate faster market access for eligible medical devices
Five decades after the “war on drugs” sought to make substance abuse unaffordable, illicit drugs are cheaper and more powerful than ever. A visit to Baltimore shows why.
<p>Doha, Qatar: With the start of the new academic year fast approaching, the Ministry of Municipality has shared a set of guidelines aimed at promoting a safe, healthy and sustainable school…
